Strain-dependent disposition of inorganic arsenic in the mouse

Toxicology

Volumn 137, Issue 2, 1999, Pages 95-108

  Hughes, Michael F ^a   Kenyon, Elaina M ^a   Edwards, Brenda C ^a   Mitchell, Carol T ^a   Thomas, David J ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Cancer; Disposition; Inorganic arsenic; Methylation; Polymorphisms

Indexed keywords

ARSENIC; ARSENIC ACID;

ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EXCRETION; FEMALE; ISOTOPE LABELING; METABOLISM; METHYLATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; ARSENATES; ARSENIC; ARSENITES; BIOTRANSFORMATION; FEMALE; INJECTIONS, INTRAPERITONEAL; METHYLATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; POISONS; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0032853110     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00068-2     Document Type: Article

References (56)

1. Bencko V., Rossner P., Havrankova H., Puzanova A., Tucek M. Effects of the combined action of selenium and arsenic on mice versus culture of mice fibroblasts. Fouts J.R., Gut I. Industrial and Environmental Xenobiotics. In Vitro Versus In Vivo Biotransformation and Atoxicity. 1978;312-316 Excerpta Medica, Amsterdam.
2. Bergdahl I.A., Gerhardsson L., Schutz A., Desnick R.J., Wetmur J.G., Skerfving S. Delta-aminolevulinic acid dehydratase polymorphisms: influence on lead levels and kidney function in humans. Arch. Environ. Health. 52:1997;91-96.
3. Bergdahl I.A., Grubb A., Schutz A., Desnick R.J., Wetmur J.G., Sassa S., Skerfving S. Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol. Toxicol. 81:1997;153-158.
4. Brouwer O.F., Okenhout W., Edelbroek P.M., de Kom J.F.M., de Wolff F.A., Peters A.C.B. Increased neurotoxicity of arsenic in methylenetetrahydrofolate reductase deficiency. Clin. Neurol. Neurosurg. 94:1992;307-310.
5. Buchet J.P., Lauwerys R. Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch. Toxicol. 57:1985;125-129.
6. Buchet J.P., Lauwerys R., Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man. Int. Arch. Occup. Environ. Health. 48:1981;71-79.
7. Chellman G.J., Shaikh Z.A., Baggs R.B. Decreased uptake and altered disposition of testicular cadmium as possible mechanisms of resistance to cadmium-induced testicular necrosis in inbred mice. Toxicology. 30:1984;157-169.
8. Chiou H.-Y., Hsueh Y.-M., Hsieh L.-L., Hsu L.-I., Hsu Y.-H., Hsieh F.-I., Wei M.-L., Chen H.-C., Yang H.-T., Leu L.-c., Chu T.-H., Chen-Wu C., Yang M.-H., Chen C.-J. Arsenic methylation capacity, body retention and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutation Res. 386:1997;197-207.
9. Cullen W.R., McBride B.C., Reglinski J. The reaction of methylarsenicals with thiols: some biological implications. J. Inorg. Biochem. 21:1984;179-194.
10. Del Razo L.M., Garcia-Vargas G.G., Vargas H., Albores A., Gonsebatt M.E., Montero R., Ostrosky-Wegman P., Kelsh M., Cebrian M.E. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch. Toxicol. 71:1997;211-217.
11. Delnomdedieu M., Basti M.M., Otvos J.D., Thomas D.J. Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study. Chem.-Biol. Interact. 90:1994;139-155.
12. Eicher E.M., Lane P.W. Assignment of LG XVI to chromosome 3 in the mouse. J. Hered. 71:1980;315-318.
13. Gunn S.A., Gould T.C., Anderson W.A.D. Strain differences in susceptibility of mice and rats to cadmium-induced testicular damage. J. Reprod. Fertil. 10:1965;273-275.
14. Healy S.M., Zakharyan R.A., Aposhian H.V. Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig. Mutation Res. 386:1997;229-239.
15. Healy S.M., Caarez E.A., Ayala-Fierro F., Aposhian H.V. Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice. Toxicol. Appl. Pharmacol. 148:1998;65-70.
16. Hopenhayn-Rich C., Smith A.M., Goeden H.M. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ. Res. 60:1993;161-177.
17. Hopenhayn-Rich C., Biggs M.L., Smith A.H., Kalman D.A., Moore L.E. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ. Health Perspect. 104:1996;620-628.
18. Hughes M.F., Kenyon E.M. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. J. Toxicol. Environ. Health. 53:1998;95-112.
19. Hughes M.F., Thompson D.J. Subchronic dispositional and toxicological effects of arsenate administered in drinking water to mice. J. Toxicol. Environ. Health. 49:1996;177-196.
20. Hughes M.F., Menache M., Thompson D.J. Dose-dependent disposition of sodium arsenate in mice following acute oral exposure. Fundam. Appl. Toxicol. 22:1994;80-89.
21. Kaise T., Watanabe S., Itoh K. The acute toxicity of arsenobetaine. Chemosphere. 14:1985;1327-1332.
22. Kaise T., Yamauchi H., Horiguchi Y., Tani T., Watanabe S., Hirayawa T., Fukui S. A comparative study on acute toxicity of methylarsonic acid, dimethylarsinic acid and trimethylarsine oxide in mice. Appl. Organomet. Chem. 3:1989;273-277.
23. Layton W.M., Layton M.W. Cadmium-induced limb defects in mice: strain associated differences in sensitivity. Teratology. 19:1979;229-236.
24. 74As]arsenite in mice and rabbits. Chem.-Biol. Interact. 50:1984;49-57.
25. Marafante E., Vahter M., Norin H., Envall J., Sandstrom M., Christakopoulos A., Ryhage R. Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol. 7:1987;111-117.
26. McIntire M.S., Angle C.R. Air lead: relation to lead in blood of black school children deficient in glucose-6-phosphate dehydrogenase. Science. 177:1972;520-522.
27. Meisler M., Orlowski C., Gross E., Bloor J.H. Cadmium metabolism in cdm/cdm mice. Biochem. Genet. 17:1979;731-736.
28. Odanaka Y., Matano O., Goto S. Biomethylation of inorganic arsenic by the rat and some laboratory animals. Bull. Environ. Contam. Toxicol. 24:1980;452-459.
29. 74As-labeled arsenate and arsenite for use in biological experiments. Anal. Biochem. 78:1977;557-560.
30. Scott N., Hatlelid K.M., MacKenzie N.E., Carter D.E. Reactions of arsenic (III) and arsenic(V) species with glutathione. Chem. Res. Toxicol. 6:1993;102-106.
31. Styblo M., Delnomdedieu M., Thomas D.J. Biological mechanism and toxicological consequences of the methylation of arsenic. Cherian M.G., Goyer R.A. Toxicology of Metals - Biochemical Aspects, Handbook of Experimental Pharmacology. 1995;407-433 Springer Verlag, Berlin.
32. Styblo M., Hughes M.F., Thomas D.J. Liberation and analysis of protein-bound arsenical. J. Chromatogr. B. 677:1996;161-166.
33. Styblo M., Serves S.V., Cullen W.R., Thomas D.J. Comparative inhibition of yeast glutathione reductase by arsenical and arsenothiols. Chem. Res. Toxicol. 10:1997;27-33.
34. Taylor B.A., Heiniger H.J., Meier H. Genetic analysis of resistance to cadmium-induced testicular damage in mice. Proc. Soc. Exp. Biol. Med. 143:1973;629-633.
35. Thompson D.J. A chemical hypothesis for arsenic methylation in mammals. Chem.-Biol. Interact. 88:1993;89-114.
36. Vahter M. Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environ. Res. 25:1981;286-293.
37. Vahter M., Marafante E. Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem.-Biol. Interact. 47:1983;29-44.
38. Vahter M., Marafante E. Reduction and binding of arsenate in marmoset monkeys. Arch. Toxicol. 57:1985;119-124.
39. Vahter M., Marafante E. In vivo methylation and detoxication of arsenic. Craig P.J., Glocking F. The Biological Alkylation of Heavy Elements. 1988;105-109 Royal Society of Chemistry, London.
40. 74As-labeled trivalent and pentavalent inorganic arsenic in mice. Environ. Res. 21:1980;446-457.
41. 74As-arsenite. Arch. Toxicol. 51:1982;65-77.
42. 74As-dimethylarsinic acid in mice and rats. Arch. Environ. Contam. Toxicol. 13:1984;259-264.
43. Vahter M., Concha G., Nermell B., Nilsson R., Dulout F., Natarajan A.T. A unique metabolism of inorganic arsenic in Andean women. Eur. J. Pharmacol. 293:1995;455-462.
44. Vahter M., Couch R., Nermell B., Nilsson R. Lack of methylation of inorganic arsenic in the chimpanzee. Toxicol. Appl. Pharmacol. 133:1995;262-268.
45. Wanibuchi H., Yamamoto S., Chen H., Yoshida K., Endo G., Hori T., Fusushima S. Promoting effects of dimethylarsinic acid to N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Carcinogenesis. 17:1996;2435-2439.
46. Weinshilboum R. Pharmacogenetics of methylation: relationship to drug metabolism. Clin. Biochem. 21:1988;201-210.
47. Wetmur J.G. Influence of a common human delta-aminolevulinic acid dehydratase polymorphism on lead body burden. Environ. Health Perspect. 102(Suppl. 3):1994;215-219.
48. Wetmur J.G., Lehnert G., Desnick R.J. The delta-aminolevulinic acid dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ. Res. 56:1991;109-119.
49. Wildfang E., Zakharyan R.A., Aposhian H.V. Enzymatic methylation of arsenic compounds. VI. Characterization of hamster liver arsenite and methylarsonic acid methyltransferase activities in vitro. Toxicol. Appl. Pharmacol. 142:1998;366-375.
50. Wolkowski R.M. Differential cadmium-induced embryotoxicity in two inbred mouse strains. Teratology. 10:1974;243-262.
51. Wolkowski-Tyl R., Preston S.F. The interaction of cadmium-binding proteins (Cd-bp) and progesterone in cadmium-induced tissue and embryo toxicity. Teratology. 20:1979;341-352.
52. Yamamoto S., Konishi Y., Matsuda T., Murai T., Shibata M.A., Matsui-Yuasa I., Otani S., Kuroda K., Endo G., Fusushima S. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55:1995;1271-1276.
53. Yamanaka K., Ohtsubo K., Hasegawa A., Hayashi H., Ojhi H., Kanisawa M., Okada S. Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice. Carcinogenesis. 17:1996;767-770.
54. Yamauchi H., Yamamura Y. Metabolism and excretion of orally administered arsenic trioxide in the hamster. Toxicology. 34:1985;113-121.
55. Zakharyan R.A., Wu Y., Bodgan G.M., Aposhian H.V. Enzymatic methylation of arsenic compounds. I. Assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 8:1995;1029-1038.
56. Zakharyan R.A., Wildfang E., Aposhian H.V. Enzymatic methylation of arsenic compounds. III. The marmoset and tamarin, but not the rhesus monkey are deficient in methyltransferases that methylate inorganic arsenic. Toxicol. Appl. Pharmacol. 140:1996;77-84.